WaferGen Biosystems Inc., a leading developer of state-of-the-art genomic analysis systems for the life science and pharmaceutical industries, recently announced that it is offering an early-access program for high-throughput Single Nucleotide Polymorphism (SNP) Genotyping through its new SmartChip Real-Time PCR System.
The company said it issued the offering in response to consumer demand for increasing speed and needs of genomics researchers. The offering is part of the company’s overall expansion based on the commercial success of its SmartChip System as the company delves into the SNP genotyping market.
“SNP Genotyping screening with the SmartChip System opens a new and large market opportunity for us, as it is focused on a $300 million addressable human and agriculture biotechnology genotyping market, part of a total SNP genotyping market of approximately $2.8 billion. By improving on SNP genotyping throughput in a flexible and low-cost manner, the SmartChip System offers researchers the ability to adopt a simple workflow for their mid-density SNP screening projects,” Alnoor Shivji, chairman and CEO of WaferGen stated in the press release.
Shivji said the company’s strategy is to maximize, expand and fully utilize SmartChip System’s applications to address the workflow challenges in the modern genomics analysis workplace.
“As we work towards the full commercial launch of the SNP Genotyping application, we plan to continue to expand on the functionality and applicability of our SmartChip System beyond Gene Expression and SNP Genotyping. This will offer researchers the most productive and cost-effective genomic analysis products,” Shivji stated.
For more information visit www.wafergen.com